Michael R.  Briggs

Michael R. Briggs Email and Phone Number

Taking a novel nanomedicine to clinical evaluation for veterinary use. Melanoma in dogs. INAD is filed, MUMS designation obtained and clinical trial in dogs with melanoma is about to start. @ PacCur Inc
Michael R. Briggs's Location
Shrewsbury, Massachusetts, United States, United States
Michael R. Briggs's Contact Details

Michael R. Briggs work email

Michael R. Briggs personal email

Michael R. Briggs phone numbers

About Michael R. Briggs

Professional ExperienceNov 2011-PresentPresident & CSO, Woodland Biosciences, Inc. a CRO specializing in preclinical models of oncology & metabolic diseases. Jul 2003 – Nov 2011Vertex, Sr. Director and Sector Head of BiologyResponsible for discovery biolog creating value in the oncology pipeline through translational medicine approaches using primary patient tumors. I spent much of the last 5 years understanding the pharmaceutical and CRO business in China. Therapeutic responsibilities ranged from neurodegenerative, oncology, inflam. and infectious diseases. Line manager for reports who led projects to clinic for telaprevir/Incivek(r) and the JAK3 molecule in Phase 2 as well as two oncology drugs that are clinical ready.

Michael R. Briggs's Current Company Details
PacCur Inc

Paccur Inc

View
Taking a novel nanomedicine to clinical evaluation for veterinary use. Melanoma in dogs. INAD is filed, MUMS designation obtained and clinical trial in dogs with melanoma is about to start.
Michael R. Briggs Work Experience Details
  • Taxolcur Llc
    Chief Scientific Officer
    Taxolcur Llc 2021 - Present
    A novel hybrid nanomedicine has been developed that will increase efficacy and reduce side effects of paclitaxel. It is a synergy of western and eastern medicines that has transformative potential to treat primary cancer and mechanisms of resistance.
  • Paccur Inc
    Chief Scientific Officer
    Paccur Inc Jun 2020 - Present
    This is the parent company of TaxolCur LLC and is focused in human cancers, particularly pancreatic as an initial focus.
  • Tufts Cummings School Of Veterinary Medicine
    Adjunct Professor
    Tufts Cummings School Of Veterinary Medicine Jan 2018 - Dec 2021
    Department of Environmental and Population Health
  • Woodland Biosciences
    President & Cso Woodland Biosciences
    Woodland Biosciences Jan 2013 - Dec 2021
  • Woodland Pharmaceuticals, Llc Dba
    President & Cso
    Woodland Pharmaceuticals, Llc Dba "Woodland Biosciences" Jun 2005 - Dec 2021
    Woodland Biosciences is a preclinical contract research organization (CRO) offering in vivo services for the study of metabolic diseases and oncology. We are located in Massachusetts, Boston metrowest, with laboratories at the Tufts Veterinary School in Grafton. Key Mouse Models:- NASH, male and female- CCl4 liver fibrosis- diet-induced obesity (DIO)- syngeneic mouse models for immuno-oncology studies- flank xenograft & orthotopic models- human primary HCC PDX- human primary PDAC PDX (in development)- PK, tolerability, necropsy servicesContact me to discuss your needs at mbriggs {at} woodlandpharma.com
  • Blend Therapeutics, Inc.
    Consultant
    Blend Therapeutics, Inc. Jan 2012 - Jun 2012
    Helped BLEND establish initial biology capabilities for their programs and design a vivarium.
  • Vertex Pharmaceuticals, Inc.
    Sr. Director, Biology
    Vertex Pharmaceuticals, Inc. Jul 2003 - Nov 2011
    Boston, Ma, Us
    Responsible for all aspects of biological sciences relating to drug discovery at the research end of the pipeline. Responsibilities on the Early Research Council (one of two project management governing bodies) ensures alignment of Biology efforts with Vertex's research portfolio up to nomination of development candidates. A small team maintained ties to the development and clinical colleagues to ensure that support for clinical candidates was maintained. Most recent activities involved establishing oncology research presence in China to build primary human tumor expertise and knowledge and drug experience base.
  • Pfizer
    Director
    Pfizer 2002 - 2003
    New York, New York, Us
    Member of Global Genomics Team with site responsibility for St. Louis. Areas of responsibility included Cardiovascular and Metabolic Diseases, Arthritis and Inflammation and Oncology.
  • Pfizer
    Director
    Pfizer 2000 - 2003
    New York, New York, Us
  • Smithkline Beecham
    Assoc. Director
    Smithkline Beecham 1998 - 2000
    Brentford, Middlesex, Gb
  • Ligand Pharmaceuticals, Inc.
    Assoc. Dir.
    Ligand Pharmaceuticals, Inc. Aug 1993 - Dec 1998
    Jupiter, Florida, Us
    Led groups in cardiovascular (lipid modofying) and metabolic disease (PPAR and retinoid biology related to diabetes and obesity).
  • Dupont
    Lab Technician
    Dupont 1969 - 1973
    Wilmington, De, Us

Michael R. Briggs Skills

Drug Discovery Biotechnology Oncology In Vitro Pharmaceutical Industry Cell Clinical Development Pharmacology Infectious Diseases Biochemistry Drug Development Biomarkers Cell Biology Biopharmaceuticals Translational Medicine Molecular Biology Cro Cancer Genomics Technology Transfer Assay Development In Vivo Cell Culture Lifesciences Purification Pharmacokinetics Validation Science Immunology Antibodies Systems Biology Clinical Research Elisa Virology Biomarker Discovery Protein Chemistry Fda High Throughput Screening Inflammation Diabetes Hplc Drug Design Dmpk Genetics Toxicology Neuroscience Pharmaceuticals Cell Based Assays Drug Delivery Animal Models

Michael R. Briggs Education Details

  • University Of California, Berkeley
    University Of California, Berkeley
    Biochemistry
  • University To Texas Southwestern Medical Center
    University To Texas Southwestern Medical Center
    Molecular Genetics
  • Ut Southwestern Medical Center
    Ut Southwestern Medical Center
    Molecular Genetics
  • University Of Zurich
    University Of Zurich
    Drosophila Eye Development
  • University Of California, Berkeley
    University Of California, Berkeley
    Biochemistry
  • University Of Delaware
    University Of Delaware
    Biology
  • The University Of Texas Southwestern Medical School
    The University Of Texas Southwestern Medical School
    Molecular Genetics

Frequently Asked Questions about Michael R. Briggs

What company does Michael R. Briggs work for?

Michael R. Briggs works for Paccur Inc

What is Michael R. Briggs's role at the current company?

Michael R. Briggs's current role is Taking a novel nanomedicine to clinical evaluation for veterinary use. Melanoma in dogs. INAD is filed, MUMS designation obtained and clinical trial in dogs with melanoma is about to start..

What is Michael R. Briggs's email address?

Michael R. Briggs's email address is mb****@****rma.com

What is Michael R. Briggs's direct phone number?

Michael R. Briggs's direct phone number is +161741*****

What schools did Michael R. Briggs attend?

Michael R. Briggs attended University Of California, Berkeley, University To Texas Southwestern Medical Center, Ut Southwestern Medical Center, University Of Zurich, University Of California, Berkeley, University Of Delaware, The University Of Texas Southwestern Medical School.

What are some of Michael R. Briggs's interests?

Michael R. Briggs has interest in Education, Environment, Science And Technology, Animal Welfare, Health.

What skills is Michael R. Briggs known for?

Michael R. Briggs has skills like Drug Discovery, Biotechnology, Oncology, In Vitro, Pharmaceutical Industry, Cell, Clinical Development, Pharmacology, Infectious Diseases, Biochemistry, Drug Development, Biomarkers.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.